Indications |
Oral Ear, nose and/or throat infections, Otitis media, Sinusitis, Pharyngo tonsillitis, Lower respiratory tract infections, Acute bacterial exacerbation of chronic bronchitis, Tracheobronchitis, Pneumonia, Urinary tract infections, Gonococcal urethritis in men Adult: 500 mg bid. |
Contraindications |
Known hypersensitivity to cephalosporins. |
Warnings / Precautions |
Hypersensitivity to penicillins. Renal insufficiency; lactation. |
Adverse Reactions |
Diarrhoea, nausea, vomiting, hypersensitivity reactions. |
Mechanism of Actions |
Cefetamet is a 3rd generation cephalosporin. It inhibits the final transpeptidation step of peptidoglycan synthesis in the bacterial cell wall by binding to one or more of the penicillin-binding proteins (PBPs). |
Storage Conditions |
Oral: Store at 25°C. |
ATC Classification |
J01DD10 - cefetamet ; Belongs to the class of third-generation cephalosporins. Used in the systemic treatment of infections. |
Storage |
Oral: Store at 25°C. |
Available As |
|
Cefetamet
Post Review about Cefetamet Click here to cancel reply.
Cefetamet Containing Brands
Cefetamet is used in following diseases
Drug - Drug Interactions of Cefetamet
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.